Feature Channels:

Article ID: 714127

A Ludwig Cancer Research study has deciphered a complex molecular conversation between cancer and immune cells that is key to orchestrating the successful invasion of tumors by T cells that kill cancer cells.

Article ID: 714147

A drug that targets the immune system can delay the onset of type 1 diabetes an average of two years in children and adults at high risk, according to findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study published in the New England Journal of Medicine.

Article ID: 713537

One of the greatest enigmas of evolutionary biology is that while sex is the dominant mode of reproduction among multicellular organisms, asexual reproduction appears much more efficient and less costly.

Article ID: 714036

Sanjay B. Maggirwar, PhD, MBA, has been selected to serve as chair of the Department of Microbiology, Immunology, and Tropical Medicine at the George Washington University School of Medicine and Health Sciences

Article ID: 713970

A UCLA-led research team has pinpointed a three-drug combination that could prove to be an effective new therapy for people with a specific type of advanced melanoma.

Article ID: 714024

Harvard Medical School’s Media Fellowship program, now entering its 22nd year, is accepting applications for Fall 2019.

Article ID: 713943

Researchers at Washington University School of Medicine in St. Louis and the Africa Health Research Institute have identified a master cell that coordinates the body’s immune defenses in the crucial early days after infection. Boosting the activity of such cells could help reduce the millions of new infections that occur worldwide every year.